Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genistein in Coronary Heart Disease
NCT00287690Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Oct 1999
- Primary completion
- Aug 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3 trial of genistein in coronary artery disease (CAD) (2 arms), sponsored by Imperial College London. Primary endpoints: Coronary Artery Diameter and Coronary Blood Flow. Started Oct 1999; status: completed.
02
Drugs
genistein
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00287690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287690.